# Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood

> **NCT00162695** · PHASE3 · TERMINATED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 400 (—)

## Conditions studied

- Rhabdomyosarcoma
- Malignant Soft Tissue

## Interventions

- **DRUG:** Ifosfamide, oncovin, actinomycine D, epirubicine, carboplatinum, etoposide

## Key facts

- **NCT ID:** NCT00162695
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1995-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 400 (—)
- **Last updated:** 2005-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162695, "Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00162695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*